Supportive
Care in Cancer, April 2016, vol./is. 24/4(1771-1777)
Mallik S.,
Mallik G., Macabulos S.T., Dorigo A.
The
goals of this study were to determine the reversibility of hypercalcaemia
amongst patients whose underlying malignancy is not being treated and assess
whether correction results in improvement in symptoms attributable to
hypercalcaemia, while identifying risk factors that can predict responsiveness. The authors found that a reduction in calcium level was associated with
a significantly prolonged survival, as well as symptomatic improvement,
irrespective of whether normocalcaemia was achieved.